Ideas

Ribonucleic acid-based therapy for enhancing memory and cognition:  LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am
Ribonucleic acid-based therapy for enhancing memory and cognition:  LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center for the Biology of…

read more

Probiotic-based therapy for body weight control, energy homeostasis, and TIIDM: Probiotic Lactobacillus Pentosus var. Plantarum C29 increases REV-ERB and its downstream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 23/January/2019, 9.57 am
Probiotic-based therapy for body weight control, energy homeostasis, and TIIDM: Probiotic Lactobacillus Pentosus var. Plantarum C29 increases REV-ERB and its downstream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 23/January/2019, 9.57 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour and metabolism by synthetic…

read more

Combinatorial therapy for Deafness: A therapeutic mix encompassing Lactobacillus plantarum AR501, Cholecalciferol, Ajoene and DIM (LPARCAD)  increases the expression of ATG5 (Autophagy-ated 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 23/January/2019, 12,04 am
Combinatorial therapy for Deafness: A therapeutic mix encompassing Lactobacillus plantarum AR501, Cholecalciferol, Ajoene and DIM (LPARCAD)  increases the expression of ATG5 (Autophagy-ated 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 23/January/2019, 12,04 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Combinatorial therapy for Deafness: A therapeutic mix encompassing Lactobacillus plantarum AR501, Cholecalciferol, Ajoene and DIM (LPARCAD)  increases the expression of ATG5…

read more

Ribonucleic acid-based therapy for autoimmune diabetes: LncRNA CASC9 increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 22/January/2018, 11.35 pm
Ribonucleic acid-based therapy for autoimmune diabetes: LncRNA CASC9 increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 22/January/2018, 11.35 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of Milan, Milan…

read more

 Ribonucleic acid-based therapy for enhancing memory and cognition:  LncRNA CYTOR increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 22/January/2019, 11.23 pm
 Ribonucleic acid-based therapy for enhancing memory and cognition:  LncRNA CYTOR increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 22/January/2019, 11.23 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center for the Biology of…

read more

Treating cardiac diseases with Zhenbao pill: Zhenbao pill-based therapy for Cardiomyopathy: Zhenbao pill decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy, via up regulation of its target gene, 22/January/2019, 11.05 pm
Treating cardiac diseases with Zhenbao pill: Zhenbao pill-based therapy for Cardiomyopathy: Zhenbao pill decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy, via up regulation of its target gene, 22/January/2019, 11.05 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart function through microRNA-mediated Sox6 repression.” This…

read more
Start Typing